Blood pressure genomics

Georg B. Ehret

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Blood pressure genetics has been instrumental in understanding the pathways that regulate blood pressure and induce hypertension. Two types of approaches have been used with great success: First, studies of hypertensive families in which monogenic blood pressure elevation can be explained by mutations in one of a dozen genes identified so far. Unfortunately, the relevance of these rare familial variants is limited when predicting primary hypertension in the general population. Second, association meta-analyses based on genome-wide genotyping using large sample sizes that have so far yielded about around 60 common genetic variants predicting blood pressure with a small, but reproducible, impact on blood pressure in the general population. This chapter summarizes the current findings based on genome-wide association studies and outlines the conclusions that can be drawn when considering the variants identified in aggregate and gives an outlook of the challenges ahead.

Original languageEnglish (US)
Title of host publicationPathophysiology and Pharmacotherapy of Cardiovascular Disease
PublisherSpringer International Publishing
Pages685-694
Number of pages10
ISBN (Print)9783319159614, 9783319159607
DOIs
StatePublished - Jan 1 2015

Fingerprint

Genomics
Blood Pressure
Hypertension
Genome-Wide Association Study
Sample Size
Population
Meta-Analysis
Genome
Mutation
Genes

Keywords

  • Blood pressure
  • Cardiovascular risk factors
  • Complex trait genetics
  • Genome-wide association studies
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Ehret, G. B. (2015). Blood pressure genomics. In Pathophysiology and Pharmacotherapy of Cardiovascular Disease (pp. 685-694). Springer International Publishing. https://doi.org/10.1007/978-3-319-15961-4_32

Blood pressure genomics. / Ehret, Georg B.

Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Springer International Publishing, 2015. p. 685-694.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ehret, GB 2015, Blood pressure genomics. in Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Springer International Publishing, pp. 685-694. https://doi.org/10.1007/978-3-319-15961-4_32
Ehret GB. Blood pressure genomics. In Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Springer International Publishing. 2015. p. 685-694 https://doi.org/10.1007/978-3-319-15961-4_32
Ehret, Georg B. / Blood pressure genomics. Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Springer International Publishing, 2015. pp. 685-694
@inbook{db4f0e1fa2314f1380fdddc231e47135,
title = "Blood pressure genomics",
abstract = "Blood pressure genetics has been instrumental in understanding the pathways that regulate blood pressure and induce hypertension. Two types of approaches have been used with great success: First, studies of hypertensive families in which monogenic blood pressure elevation can be explained by mutations in one of a dozen genes identified so far. Unfortunately, the relevance of these rare familial variants is limited when predicting primary hypertension in the general population. Second, association meta-analyses based on genome-wide genotyping using large sample sizes that have so far yielded about around 60 common genetic variants predicting blood pressure with a small, but reproducible, impact on blood pressure in the general population. This chapter summarizes the current findings based on genome-wide association studies and outlines the conclusions that can be drawn when considering the variants identified in aggregate and gives an outlook of the challenges ahead.",
keywords = "Blood pressure, Cardiovascular risk factors, Complex trait genetics, Genome-wide association studies, Single nucleotide polymorphism",
author = "Ehret, {Georg B.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-15961-4_32",
language = "English (US)",
isbn = "9783319159614",
pages = "685--694",
booktitle = "Pathophysiology and Pharmacotherapy of Cardiovascular Disease",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Blood pressure genomics

AU - Ehret, Georg B.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Blood pressure genetics has been instrumental in understanding the pathways that regulate blood pressure and induce hypertension. Two types of approaches have been used with great success: First, studies of hypertensive families in which monogenic blood pressure elevation can be explained by mutations in one of a dozen genes identified so far. Unfortunately, the relevance of these rare familial variants is limited when predicting primary hypertension in the general population. Second, association meta-analyses based on genome-wide genotyping using large sample sizes that have so far yielded about around 60 common genetic variants predicting blood pressure with a small, but reproducible, impact on blood pressure in the general population. This chapter summarizes the current findings based on genome-wide association studies and outlines the conclusions that can be drawn when considering the variants identified in aggregate and gives an outlook of the challenges ahead.

AB - Blood pressure genetics has been instrumental in understanding the pathways that regulate blood pressure and induce hypertension. Two types of approaches have been used with great success: First, studies of hypertensive families in which monogenic blood pressure elevation can be explained by mutations in one of a dozen genes identified so far. Unfortunately, the relevance of these rare familial variants is limited when predicting primary hypertension in the general population. Second, association meta-analyses based on genome-wide genotyping using large sample sizes that have so far yielded about around 60 common genetic variants predicting blood pressure with a small, but reproducible, impact on blood pressure in the general population. This chapter summarizes the current findings based on genome-wide association studies and outlines the conclusions that can be drawn when considering the variants identified in aggregate and gives an outlook of the challenges ahead.

KW - Blood pressure

KW - Cardiovascular risk factors

KW - Complex trait genetics

KW - Genome-wide association studies

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=84944097691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944097691&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-15961-4_32

DO - 10.1007/978-3-319-15961-4_32

M3 - Chapter

SN - 9783319159614

SN - 9783319159607

SP - 685

EP - 694

BT - Pathophysiology and Pharmacotherapy of Cardiovascular Disease

PB - Springer International Publishing

ER -